PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

A universal Ebola drug target

New study reports design, characterization of universally conserved drug target for current, future strains of virus

2014-10-07
(Press-News.org) (SALT LAKE CITY)—University of Utah biochemists have reported a new drug discovery tool against the Ebola virus. According to a study published in this week's online edition of Protein Science, they have produced a molecule, known as a peptide mimic, that displays a functionally critical region of the virus that is universally conserved in all known species of Ebola. This new tool can be used as a drug target in the discovery of anti-Ebola agents that are effective against all known strains and likely future strains.

The University of Utah (U of U) work, which was funded by the National Institutes of Health, was conducted by a large collaborative team led by Debra Eckert, Ph.D., (research assistant professor of biochemistry) and Michael Kay, M.D., Ph.D., (professor of biochemistry). Key contributions to this work were provided by Dr. John Dye's laboratory at the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID), the lab of Christopher P. Hill, D.Phil., professor and co-chair of the U of U Department of Biochemistry, and a group led by Brett Welch, Ph.D. at Navigen, Inc., a Salt Lake City pharmaceutical discovery and development company. (Navigen has licensed exclusive rights to the technology from the U of U and is currently screening for drugs against the target.)

The Utah scientists designed peptide mimics of a highly conserved region in the Ebola protein that controls entry of the virus into the human host cell, initiating infection. Importantly, the researchers were able to demonstrate this peptide target is suitable for use in high-throughput drug screens. These kinds of screens allow rapid identification of potential new drugs from billions of possible candidates.

Current experimental drugs generally target only one of Ebola's five species. "The current growing epidemic demonstrates the need for effective broad-range Ebola virus therapies," says Dr. Tracy R. Clinton, lead author on the study. "Importantly, viral sequence information from the epidemic reveals rapid changes in the viral genome, while our target sequence remains the same. Therefore, our target will enable the discovery of drugs with the potential to treat any future epidemic, even if new Ebola virus strains emerge."

Ebola is a lethal virus that causes severe hemorrhagic fever with a 50 percent to 90 percent mortality rate. There are five known species of the virus. Outbreaks have been occurring with increasing frequency in recent years, and an unprecedented and rapidly expanding Ebola outbreak is currently spreading through several countries in West Africa with devastating consequences. The development of an effective anti-Ebola agent to protect against natural outbreaks and potential bioterror exposures is an urgent global health need. There are no approved anti-Ebola agents, but a number of promising experimental drugs are being aggressively advanced to clinical trials to address the current crisis.

Dr. Eckert notes, "Although the current push of clinical trials will hopefully lead to an effective treatment for the Zaire species causing the present epidemic, the same treatments are unlikely to be effective against future outbreaks of a different or new Ebola species. Development of a broadly acting therapy is an important long-term goal that would allow cost-effective stockpiling of a universal Ebola treatment."

Of particular interest, this target was shown to be suitable for the discovery of mirror-image peptide inhibitors (D-peptides), which are promising drug candidates. Unlike natural peptides, they are not digested by enzymes in the blood. D-peptides are also much simpler and less expensive to produce compared to the current most promising approach, antibodies. The Utah group has previously developed highly potent and broadly acting D-peptide inhibitors of HIV entry, currently in preclinical studies, and is now adapting this approach to Ebola using the mimics developed in this study. In collaboration with Navigen, several promising lead D-peptide inhibitors have already been identified. U of U and Navigen are now seeking additional funding to optimize these inhibitors and advance them into clinical trials in humans.

INFORMATION:



ELSE PRESS RELEASES FROM THIS DATE:

Hypoglycemia link to HbA1c has declined in type 1 diabetes

2014-10-07
The link between low average glucose blood levels and greater risk for severe hypoglycemia and hypoglycemic coma substantially declined between 1995 and 2012 in young Germans and Austrians with type 1 diabetes, according to a study published by Beate Karges and colleagues from the RWTH Aachen University, Germany in this week's PLOS Medicine. The researchers obtained measurements of average blood glucose levels (measured as HbA1c) and the incidents of severe hypoglycemia and hypoglycemic coma from 37,539 children and young adults with type 1 diabetes between 1995 and 2012 ...

Oral chelation for environmental lead toxicity

2014-10-07
Treatment with dimercaptosuccinic acid (DMSA), an oral chelation agent, was linked to reductions in the amount of lead in blood in young children in Zamfara State, Nigeria following environmental lead contamination, according to a study by Jane Greig and colleagues from Médecins Sans Frontières (MSF) published in this week's PLOS Medicine. The researchers report findings from an MSF program initiated in May 2010 to reduce lead poisoning in children following widespread environmental lead contamination due to gold mining in Zamfara State, Nigeria, leading to ...

How female flies know when to say 'yes'

2014-10-07
A fundamental question in neurobiology is how animals, including humans, make decisions. A new study publishing in the open access journal PLOS Biology on October 7 reveals how fruit fly females make a very important decision: to either accept or reject male courtship. This decision appears to be generated by a very small number of excitatory neurons that use acetylcholine as their neurotransmitter located in three brain regions. This study provides the framework to understand how decisions are generated and suggests that a decision is reached because that option is literally ...

New at-risk group identified for gastrointestinal stromal tumors

New at-risk group identified for gastrointestinal stromal tumors
2014-10-07
Researchers at the University of California, San Diego School of Medicine have, for the first time, clearly defined the epidemiology of gastrointestinal stromal tumors (GIST), which occur primarily in the lining of the stomach and small intestine. One key finding: Patients of Asian descent, who have not previously been identified as an at-risk population, are 1.5 times more likely than other patient groups to be diagnosed with this type of tumor. Results of the study were published this week in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association ...

George Washington physician addresses stigma against patients and providers with disabilities

2014-10-07
WASHINGTON (Oct. 7, 2014) — Nearly 20 percent of Americans have a disability, yet only 25 percent of medical schools include in their curricula caring for people with disabilities. Numerous reports have documented that people with disabilities have poorer health and receive inferior care. In a Narrative Matters essay published in Health Affairs, Leana Wen, M.D., director of patient-centered care research and assistant professor of emergency medicine at the George Washington University School of Medicine and Health Sciences, shares her own experiences to highlight ...

Survival molecule helps cancer cells hide from the immune system

2014-10-07
COLUMBUS, Ohio – A molecule that helps cancer cells evade programmed self-destruction, an internal source of death, might also help malignant cells hide from the immune system, an external source of death. A new study by researchers at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) shows that a molecule called nuclear factor kappa B (NF-kB) helps cancer cells by inhibiting the immune system's ability to detect and destroy them. The molecule regulates genes ...

Researchers identify 'Achilles heel' in metabolic pathway that could lead to new cancer treatment

Researchers identify Achilles heel in metabolic pathway that could lead to new cancer treatment
2014-10-07
DALLAS – Oct. 7, 2014 – Researchers at UT Southwestern Medical Center have found an "Achilles heel" in a metabolic pathway crucial to stopping the growth of lung cancer cells. At the heart of this pathway lies PPARγ (peroxisome proliferation-activated receptor gamma), a protein that regulates glucose and lipid metabolism in normal cells. Researchers demonstrated that by activating PPARγ with antidiabetic drugs in lung cancer cells, they could stop these tumor cells from dividing. "We found that activation of PPARγ causes a major metabolic ...

State policies can influence access to heroin treatment, study finds

2014-10-07
State policies can influence the number of physicians licensed to prescribe buprenorphine, a drug that can treat addiction to heroin and other opioids in outpatient settings, according to a new RAND Corporation study. Examining county-level numbers of physicians approved to prescribe buprenorphine, researchers found a significant link between the number of approved physicians and both specific state guidance regarding the use of buprenorphine and the distribution of clinical guidelines for buprenorphine treatment. The findings were published online by the Journal of ...

Sleeping in dentures doubles the risk of pneumonia in the elderly

2014-10-07
Alexandria, Va., USA – Poor oral health and hygiene are increasingly recognized as major risk factors for pneumonia among the elderly. To identify modifiable oral health-related risk factors, lead researcher Toshimitsu Iinuma, Nihon University School of Dentistry, Japan, and a team of researchers prospectively investigated associations between a constellation of oral health behaviors and incidences of pneumonia in the community-living of elders 85 years of age or older. This study, titled "Denture Wearing During Sleep Doubles the Risk of Pneumonia in Very Elderly," ...

The sex difference in distance running has disappeared for participation but not for competitiveness

The sex difference in distance running has disappeared for participation but not for competitiveness
2014-10-07
ALLENDALE, Mich. — Even among contemporary U.S. distance runners, men are still much more likely than women to have a competitive orientation, according to researchers at Grand Valley State University in Allendale, Michigan. The findings were published in the online journal, Evolutionary Psychology at http://www.epjournal.net/articles/u-s-masters-track-participation-reveals-a-stable-sex-difference-in-competitiveness/ The new research, led by Robert Deaner, associate professor of psychology at Grand Valley State, shows that, on average, American men participate at ...

LAST 30 PRESS RELEASES:

Robotic space rovers keep getting stuck. UW engineers have figured out why

New research shows how immigration status can become a death sentence during public health crisis

University of Toronto Engineering researchers develop safer alternative non-stick coating

Good vibrations: Scientists use imaging technology to visualize heat

More ecological diversity means better nutritional resources in Fiji’s agroforests

New global study shows freshwater is disappearing at alarming rates

Scientists create an artificial cell capable of navigating its environment using chemistry alone

A little salt is good for battery health

Deep-sea fish confirmed as a significant source of ocean carbonate

How to keep kids with eating disorders home after hospital stay? Therapy

Sex differences affect efficacy of opioid overdose treatment

Aligning AI with Human Values and Well-Being

Engineering the next generation of experimental physics

The scuba diving industry is funding marine ecosystem conservation and employing locals

BATMAN brings TCR therapy out of the shadows

Surrogates more likely to be diagnosed with mental illness, study finds

Columbia Engineering researchers turn dairy byproduct into tissue repair gel

Global estimates of lives and life-years saved by COVID-19 vaccination during 2020-2024

Potential trade-offs of proposed cuts to the NIH

New research simulates cancer cell behavior

COVID, over 2.5 million deaths prevented worldwide thanks to vaccines. One life saved for every 5,400 doses administered

Scuba diving generates up to $20 billion annually

Scientists advance efforts to create ‘virtual cell lab’ as testing ground for future research with live cells

How DNA packaging controls the “genome’s guardian”

Simplified models, deeper insights: Coarse-grained models unlock new potential for ionic liquid simulations

Gorillas’ personal circumstances shape their aggression towards groupmates

Which signalling pathways in the cell lead to possible therapies for Parkinson's disease

Identifying landslide threats using hydrological predictors

First graders who use more educational media spend more time reading

Exploring the meaning in life through phenomenology and philosophy

[Press-News.org] A universal Ebola drug target
New study reports design, characterization of universally conserved drug target for current, future strains of virus